These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22665141)

  • 1. Variants in the HEPSIN gene are associated with susceptibility to prostate cancer.
    Kim HJ; Han JH; Chang IH; Kim W; Myung SC
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):353-8. PubMed ID: 22665141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the HEPSIN gene are associated with prostate cancer in men of European origin.
    Pal P; Xi H; Kaushal R; Sun G; Jin CH; Jin L; Suarez BK; Catalona WJ; Deka R
    Hum Genet; 2006 Sep; 120(2):187-92. PubMed ID: 16783571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of hepsin gene variants with prostate cancer risk and prognosis.
    Holt SK; Kwon EM; Lin DW; Ostrander EA; Stanford JL
    Prostate; 2010 Jun; 70(9):1012-9. PubMed ID: 20166135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progression.
    Kim MS; Lee HN; Kim HJ; Myung SC
    Int Braz J Urol; 2015; 41(5):869-97. PubMed ID: 26689513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence variants of Toll-like receptor 4 (TLR4) and the risk of prostate cancer in Korean men.
    Kim HJ; Bae JS; Chang IH; Kim KD; Lee J; Shin HD; Lee JY; Kim WJ; Kim W; Myung SC
    World J Urol; 2012 Apr; 30(2):225-32. PubMed ID: 21553150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphisms in fibroblast growth factor 23 gene, FGF23, are associated with prostate cancer risk.
    Kim HJ; Kim KH; Lee J; Oh JJ; Cheong HS; Wong EL; Yang BS; Byun SS; Myung SC
    BJU Int; 2014 Aug; 114(2):303-10. PubMed ID: 24053368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
    Choi SY; Kim HJ; Cheong HS; Myung SC
    Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HNF1B polymorphism associated with development of prostate cancer in Korean patients.
    Kim HJ; Bae JS; Lee J; Chang IH; Kim KD; Shin HD; Han JH; Lee SY; Kim W; Myung SC
    Urology; 2011 Oct; 78(4):969.e1-6. PubMed ID: 21982019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
    Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
    Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility loci associations with prostate cancer risk in northern Chinese men.
    Wang NN; Xu Y; Yang K; Wei D; Zhang YG; Liu M; Shi XH; Liang SY; Sun L; Zhu XQ; Yang YG; Tang L; Zhao CX; Wang X; Chen X; Hui J; Zhang YH; Zhu L; Yang F; Zhang YR; Yang Z; Wang JY
    Asian Pac J Cancer Prev; 2013; 14(5):3075-8. PubMed ID: 23803082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between KL polymorphism and prostate cancer risk in Korean patients.
    Kim HJ; Lee J; Lee SY; Cheong HS; Kye YS; Kim W; Byun SS; Myung SC
    Mol Biol Rep; 2014 Nov; 41(11):7595-606. PubMed ID: 25120167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort.
    Chan JY; Li H; Singh O; Mahajan A; Ramasamy S; Subramaniyan K; Kanesvaran R; Sim HG; Chong TW; Teo YY; Chia SE; Tan MH; Chowbay B
    Urol Oncol; 2013 Nov; 31(8):1553-60. PubMed ID: 22561070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
    Liu M; Suzuki M; Arai T; Sawabe M; Enomoto Y; Nishimatsu H; Kume H; Homma Y; Kitamura T
    Prostate; 2011 Jul; 71(10):1023-32. PubMed ID: 21557267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
    Kim S; Shin C; Jee SH
    Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.